A citation-based method for searching scientific literature

Lukas M Schilde, Steffen Kösters, Simone Steinbach, Karin Schork, Martin Eisenacher, Sara Galozzi, Michael Turewicz, Katalin Barkovits, Brit Mollenhauer, Katrin Marcus, Caroline May. PLoS One 2018
Times Cited: 15







List of co-cited articles
53 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease.
Gajanan Sathe, Chan Hyun Na, Santosh Renuse, Anil K Madugundu, Marilyn Albert, Abhay Moghekar, Akhilesh Pandey. Proteomics Clin Appl 2019
46
26

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
C E Teunissen, A Petzold, J L Bennett, F S Berven, L Brundin, M Comabella, D Franciotta, J L Frederiksen, J O Fleming, R Furlan,[...]. Neurology 2009
504
20

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects.
Eduardo M Castaño, Alex E Roher, Chera L Esh, Tyler A Kokjohn, Thomas Beach. Neurol Res 2006
158
20

Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults.
Loïc Dayon, Ornella Cominetti, Jérôme Wojcik, Antonio Núñez Galindo, Aikaterini Oikonomidi, Hugues Henry, Eugenia Migliavacca, Martin Kussmann, Gene L Bowman, Julius Popp. J Proteome Res 2019
23
20

Development and functions of the choroid plexus-cerebrospinal fluid system.
Melody P Lun, Edwin S Monuki, Maria K Lehtinen. Nat Rev Neurosci 2015
265
20

Cerebrospinal fluid proteomics implicates the granin family in Parkinson's disease.
Melissa S Rotunno, Monica Lane, Wenfei Zhang, Pavlina Wolf, Petra Oliva, Catherine Viel, Anne-Marie Wills, Roy N Alcalay, Clemens R Scherzer, Lamya S Shihabuddin,[...]. Sci Rep 2020
29
20

Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.
Erik C B Johnson, Eric B Dammer, Duc M Duong, Lingyan Ping, Maotian Zhou, Luming Yin, Lenora A Higginbotham, Andrew Guajardo, Bartholomew White, Juan C Troncoso,[...]. Nat Med 2020
268
20

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.
Marta del Campo, Brit Mollenhauer, Antonio Bertolotto, Sebastiaan Engelborghs, Harald Hampel, Anja Hviid Simonsen, Elisabeth Kapaki, Niels Kruse, Nathalie Le Bastard, Sylvain Lehmann,[...]. Biomark Med 2012
231
13

Characterization of Cerebrospinal Fluid via Data-Independent Acquisition Mass Spectrometry.
Katalin Barkovits, Andreas Linden, Sara Galozzi, Lukas Schilde, Sandra Pacharra, Brit Mollenhauer, Nadine Stoepel, Simone Steinbach, Caroline May, Julian Uszkoreit,[...]. J Proteome Res 2018
19
13

Protein biomarkers in Parkinson's disease: Focus on cerebrospinal fluid markers and synaptic proteins.
Steffen Halbgebauer, Patrick Öckl, Katharina Wirth, Petra Steinacker, Markus Otto. Mov Disord 2016
44
13


2016 update of the PRIDE database and its related tools.
Juan Antonio Vizcaíno, Attila Csordas, Noemi del-Toro, José A Dianes, Johannes Griss, Ilias Lavidas, Gerhard Mayer, Yasset Perez-Riverol, Florian Reisinger, Tobias Ternent,[...]. Nucleic Acids Res 2016
13

The impact of blood contamination on the proteome of cerebrospinal fluid.
Jin-Sam You, Valentina Gelfanova, Michael D Knierman, Frank A Witzmann, Mu Wang, John E Hale. Proteomics 2005
89
13

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.
Daniel S Spellman, Kristin R Wildsmith, Lee A Honigberg, Marianne Tuefferd, David Baker, Nandini Raghavan, Angus C Nairn, Pascal Croteau, Michael Schirm, Rene Allard,[...]. Proteomics Clin Appl 2015
83
13

Role for the neurexin-neuroligin complex in Alzheimer's disease.
Ikhlas A Sindi, Rudolph K Tannenberg, Peter R Dodd. Neurobiol Aging 2014
34
13

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.
Franc Llorens, Katrin Thüne, Waqas Tahir, Eirini Kanata, Daniela Diaz-Lucena, Konstantinos Xanthopoulos, Eleni Kovatsi, Catharina Pleschka, Paula Garcia-Esparcia, Matthias Schmitz,[...]. Mol Neurodegener 2017
93
13

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease.
Payam Emami Khoonsari, Anna Häggmark, Maria Lönnberg, Maria Mikus, Lena Kilander, Lars Lannfelt, Jonas Bergquist, Martin Ingelsson, Peter Nilsson, Kim Kultima,[...]. PLoS One 2016
59
13

Neuronal pentraxin receptor-1 is a new cerebrospinal fluid biomarker of Alzheimer's disease progression.
Ilijana Begcevic, Magda Tsolaki, Davor Brinc, Marshall Brown, Eduardo Martinez-Morillo, Ioulietta Lazarou, Mahi Kozori, Fani Tagaraki, Stella Nenopoulou, Mara Gkioka,[...]. F1000Res 2018
23
13


Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.
Richard J Perrin, Rebecca Craig-Schapiro, James P Malone, Aarti R Shah, Petra Gilmore, Alan E Davis, Catherine M Roe, Elaine R Peskind, Ge Li, Douglas R Galasko,[...]. PLoS One 2011
131
13

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.
Fadi Abdi, Joseph F Quinn, Joseph Jankovic, Martin McIntosh, James B Leverenz, Elaine Peskind, Randy Nixon, John Nutt, Katherine Chung, Cyrus Zabetian,[...]. J Alzheimers Dis 2006
295
13

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.
Tobias Skillbäck, Niklas Mattsson, Karl Hansson, Ekaterina Mirgorodskaya, Rahil Dahlén, Wiesje van der Flier, Philip Scheltens, Floor Duits, Oskar Hansson, Charlotte Teunissen,[...]. Sci Rep 2017
16
13

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease.
Christopher D Whelan, Niklas Mattsson, Michael W Nagle, Swetha Vijayaraghavan, Craig Hyde, Shorena Janelidze, Erik Stomrud, Julie Lee, Lori Fitz, Tarek A Samad,[...]. Acta Neuropathol Commun 2019
74
13

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.
Alberto Lleó, Raúl Núñez-Llaves, Daniel Alcolea, Cristina Chiva, Daniel Balateu-Paños, Martí Colom-Cadena, Gemma Gomez-Giro, Laia Muñoz, Marta Querol-Vilaseca, Jordi Pegueroles,[...]. Mol Cell Proteomics 2019
33
13

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.
Gunnar Brinkmalm, Simon Sjödin, Anja Hviid Simonsen, Steen Gregers Hasselbalch, Henrik Zetterberg, Ann Brinkmalm, Kaj Blennow. Proteomics Clin Appl 2018
64
13

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Bob Olsson, Ronald Lautner, Ulf Andreasson, Annika Öhrfelt, Erik Portelius, Maria Bjerke, Mikko Hölttä, Christoffer Rosén, Caroline Olsson, Gabrielle Strobel,[...]. Lancet Neurol 2016
999
13

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid.
Ronald C Hendrickson, Anita Y H Lee, Qinghua Song, Andy Liaw, Matt Wiener, Cloud P Paweletz, Jeffrey L Seeburger, Jenny Li, Fanyu Meng, Ekaterina G Deyanova,[...]. PLoS One 2015
45
13

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer's disease: A literature review.
Kirsten E J Wesenhagen, Charlotte E Teunissen, Pieter Jelle Visser, Betty M Tijms. Crit Rev Clin Lab Sci 2020
24
13

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.
Alberto Lleó, Raúl Núñez-Llaves, Daniel Alcolea, Cristina Chiva, Daniel Balateu-Paños, Martí Colom-Cadena, Gemma Gomez-Giro, Laia Muñoz, Marta Querol-Vilaseca, Jordi Pegueroles,[...]. Mol Cell Proteomics 2019
64
13

Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.
Kristin R Wildsmith, Stephen P Schauer, Ashley M Smith, David Arnott, Yuda Zhu, Joshua Haznedar, Surinder Kaur, W Rodney Mathews, Lee A Honigberg. Mol Neurodegener 2014
92
13

Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.
Wendy E Heywood, Daniela Galimberti, Emily Bliss, Ernestas Sirka, Ross W Paterson, Nadia K Magdalinou, Miryam Carecchio, Emma Reid, Amanda Heslegrave, Chiara Fenoglio,[...]. Mol Neurodegener 2015
85
13

Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid.
Baharak Vafadar-Isfahani, Graham Ball, Clare Coveney, Christophe Lemetre, David Boocock, Lennart Minthon, Oskar Hansson, Amanda Kathleen Miles, Sabina M Janciauskiene, Donald Warden,[...]. J Alzheimers Dis 2012
47
13

Alzheimer disease pathology and the cerebrospinal fluid proteome.
Loïc Dayon, Antonio Núñez Galindo, Jérôme Wojcik, Ornella Cominetti, John Corthésy, Aikaterini Oikonomidi, Hugues Henry, Martin Kussmann, Eugenia Migliavacca, India Severin,[...]. Alzheimers Res Ther 2018
37
13

Emergence and Developmental Roles of the Cerebrospinal Fluid System.
Ryann M Fame, Maria K Lehtinen. Dev Cell 2020
74
13

Age-Dependent Niche Signals from the Choroid Plexus Regulate Adult Neural Stem Cells.
Violeta Silva-Vargas, Angel R Maldonado-Soto, Dogukan Mizrak, Paolo Codega, Fiona Doetsch. Cell Stem Cell 2016
175
13

Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
Simona Vuletic, Elaine R Peskind, Santica M Marcovina, Joseph F Quinn, Marian C Cheung, Hal Kennedy, Jeffrey A Kaye, Lee-Way Jin, John J Albers. J Neurosci Res 2005
41
13

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.
K Blennow, P Fredman, A Wallin, C G Gottfries, I Karlsson, G Långström, I Skoog, L Svennerholm, C Wikkelsö. Eur Neurol 1993
143
13

TANDEM: matching proteins with tandem mass spectra.
Robertson Craig, Ronald C Beavis. Bioinformatics 2004
13

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.
Manuel Comabella, Marta Fernández, Roland Martin, Stephanie Rivera-Vallvé, Eva Borrás, Cristina Chiva, Eva Julià, Alex Rovira, Ester Cantó, Jose Carlos Alvarez-Cermeño,[...]. Brain 2010
201
13

Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.
Joan Montaner, Laura Ramiro, Alba Simats, Steffen Tiedt, Konstantinos Makris, Glen C Jickling, Stephanie Debette, Jean-Charles Sanchez, Alejandro Bustamante. Nat Rev Neurol 2020
74
13

In-depth characterization of the cerebrospinal fluid (CSF) proteome displayed through the CSF proteome resource (CSF-PR).
Astrid Guldbrandsen, Heidrun Vethe, Yehia Farag, Eystein Oveland, Hilde Garberg, Magnus Berle, Kjell-Morten Myhr, Jill A Opsahl, Harald Barsnes, Frode S Berven. Mol Cell Proteomics 2014
98
13

Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics.
Amelia C Peterson, Jason D Russell, Derek J Bailey, Michael S Westphall, Joshua J Coon. Mol Cell Proteomics 2012
743
13

In-Depth Cerebrospinal Fluid Quantitative Proteome and Deglycoproteome Analysis: Presenting a Comprehensive Picture of Pathways and Processes Affected by Multiple Sclerosis.
Ann Cathrine Kroksveen, Astrid Guldbrandsen, Marc Vaudel, Ragnhild Reehorst Lereim, Harald Barsnes, Kjell-Morten Myhr, Øivind Torkildsen, Frode S Berven. J Proteome Res 2017
22
13

Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges.
Andreas F Hühmer, Roger G Biringer, Heidi Amato, Alfred N Fonteh, Michael G Harrington. Dis Markers 2006
114
13

Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.
Min Shi, James Movius, Romel Dator, Patrick Aro, Yanchun Zhao, Catherine Pan, Xiangmin Lin, Theo K Bammler, Tessandra Stewart, Cyrus P Zabetian,[...]. Mol Cell Proteomics 2015
45
13

Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS.
Michael S Bereman, Joshua Beri, Jeffrey R Enders, Tara Nash. Sci Rep 2018
21
13

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease.
Lenora Higginbotham, Lingyan Ping, Eric B Dammer, Duc M Duong, Maotian Zhou, Marla Gearing, Cheyenne Hurst, Jonathan D Glass, Stewart A Factor, Erik C B Johnson,[...]. Sci Adv 2020
56
13

A comprehensive systematic review of CSF proteins and peptides that define Alzheimer's disease.
Cristina M Pedrero-Prieto, Sonia García-Carpintero, Javier Frontiñán-Rubio, Emilio Llanos-González, Cristina Aguilera García, Francisco J Alcaín, Iris Lindberg, Mario Durán-Prado, Juan R Peinado, Yoana Rabanal-Ruiz. Clin Proteomics 2020
24
13

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease.
Jakob M Bader, Philipp E Geyer, Johannes B Müller, Maximilian T Strauss, Manja Koch, Frank Leypoldt, Peter Koertvelyessy, Daniel Bittner, Carola G Schipke, Enise I Incesoy,[...]. Mol Syst Biol 2020
58
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.